Millie Ray

Dr. Millie Ray currently serves as a Partner at The Column Group, operating as a venture capital investor dedicated to the life sciences sector. She initially joined the investment firm in 2017 and advanced through the organization's internal ranks, securing a promotion from her prior role as a Principal to her current partnership position. Ray holds a Doctor of Philosophy degree, which provides the foundational scientific expertise required to rigorously evaluate complex biotechnology, pharmaceutical, and therapeutic investment opportunities. Throughout her tenure at the firm, she has specialized in identifying early-stage scientific discoveries and supporting the development of emerging companies within the highly technical healthcare landscape. Her professional background combines advanced academic research credentials with institutional investment experience to guide strategic capital allocation. Today, her primary focus remains centered on deploying venture capital to scale innovative life sciences enterprises.